What acne-scar research can tell you about microneedling sessions, why depth charts are limited, and what to ask before treatment.
There is no universal microneedling depth and frequency chart that reliably turns a home device into an acne-scar or wrinkle treatment. Clinical evidence concerns particular devices, patients and procedures. A needle-length label alone cannot tell you which skin layer will be reached or when another session is appropriate.
A 2014 randomized split-face trial enrolled 20 adults with acne scars; 15 completed follow-up. One facial side received three needling treatments at two-week intervals. Blinded dermatologists assessed photographs at three and six months.
The treated side's scar score improved significantly from baseline at six months, while its three-month change narrowly missed statistical significance. The untreated side did not show a significant change. No adverse events were reported in this small study.
That is useful evidence for the studied procedure, with important limits: five participants did not complete follow-up, and the sample cannot establish the frequency of uncommon harms. The study did not compare weekly, monthly and longer intervals. Its schedule therefore cannot identify the best interval, validate a home routine or establish a six-month waiting rule for every skin concern. This summary uses the original published abstract; the full trial report was not available for this review.
Needle length and actual penetration are different measurements. In a laboratory microneedle experiment, penetration changed with application force even though the needle array stayed the same. Excised rat and human skin also behaved differently. This is evidence about a particular experimental system, not a depth-selection guide for the face.
A chart assigning every 0.5 mm device to the same tissue layer omits those differences. The studies discussed here do not validate the former advice on this page to use daily shallow needling, weekly deeper needling, or bleeding as a home treatment target.
Ask the treating clinician to explain the target condition, device and treatment area together. Acne depressions, flat discoloration and facial wrinkles are different outcomes; improvement in one cannot be assumed to prove improvement in the others.
The FDA's consumer guidance distinguishes superficial exfoliating products from medical devices that penetrate living tissue. It has not authorized microneedling medical devices for over-the-counter sale. A device being available to buy online does not establish that its proposed home use was reviewed.
Radiofrequency microneedling also delivers heat. In its October 2025 safety communication, the FDA reported serious complications including burns, scarring, fat loss and nerve damage, and advised against home use. That notice does not provide a complication rate or establish that every device and use has the same risk. It does rule out treating RF as an automatic upgrade from ordinary needling.
The FDA's patient information identifies infection, pigment changes and cold-sore reactivation among potential harms. Bleeding disorders, immune suppression, active infection and other health factors may affect suitability. Ask about a new needle cartridge for every session; cleaning a used cartridge does not make reuse consistent with FDA authorization.
The American Academy of Dermatology describes gradual results and individualized preparation and aftercare, which may include pausing retinoids. Get instructions for your treatment instead of borrowing a fixed restart interval from a forum. Contact the treating clinician if recovery is worsening or differs from the advice you were given.
If the proposed reason for needling is to make a serum penetrate, read what peptide-delivery research actually measures before accepting that as evidence of added benefit.
Powered by BTST